Logotype for Plus Therapeutics Inc

Plus Therapeutics (PSTV) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Plus Therapeutics Inc

Proxy filing summary

31 Mar, 2026

Voting matters and shareholder proposals

  • Election of six directors for a one-year term, with nominees listed for shareholder approval.

  • Ratification of CBIZ P.C. as the independent registered public accounting firm for the 2026 fiscal year.

  • Advisory vote on executive compensation for named executive officers.

  • Approval of the Sixth Amendment and Restatement of the 2020 Stock Incentive Plan.

  • Additional business may be transacted as properly brought before the meeting.

Board of directors and corporate governance

  • Six director nominees are presented for election, each to serve until the 2027 annual meeting or until a successor is elected.

Executive compensation and say-on-pay

  • Shareholders are asked to provide a non-binding advisory vote on the compensation of named executive officers.

  • Proposal includes approval of amendments to the 2020 Stock Incentive Plan.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more